<?xml version="1.0" encoding="UTF-8"?>
<ref id="B19">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cuburu</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Khan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Thompson</surname>
    <given-names>C. D.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Vellinga</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Zahn</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2018</year>). 
  <article-title>Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8(+) T cell responses against HPV16 oncoproteins</article-title>. 
  <source>Int. J. Cancer</source>
  <volume>142</volume>, 
  <fpage>1467</fpage>â€“
  <lpage>1479</lpage>. 
  <pub-id pub-id-type="doi">10.1002/ijc.31166</pub-id>
  <?supplied-pmid 29159802?>
  <pub-id pub-id-type="pmid">29159802</pub-id>
 </mixed-citation>
</ref>
